✦ LIBER ✦

Berlex has launched its oral contraceptive ethinylestradiol/drospirenone [`Yasmin'] in the US,

✍ Scribed by Soni, Sushma

Book ID: 120866278
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2001
Weight: 151 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200112960-00034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of the Combined Oral

Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/ Drospirenone (Yasmin®) in Healthy Chinese Women

✍ Dr Fan Guang-Sheng, Bian Mei-Lu, Cheng Li-Nan, Cao Xiao-Ming, Huang Zi-Rong, Han 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 156 KB

Venous thromboembolism after high-dose c

Venous thromboembolism after high-dose chemotherapy in a patient with Hodgkin's lymphoma receiving the new oral contraceptive ethinylestradiol and drospirenone (‘Yasmine’)

✍ Tartarone, A; Gallucci, G; Cammarota, A; Romano, G; Ardito, R; Di Renzo, N 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 60 KB

The use of an oral contraceptive contain

The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days

✍ Jean-Michel Foidart; Patricia J. Sulak; Ilka Schellschmidt; Doris Zimmermann 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 246 KB